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We present a novel electrochemical sensor that was developed by modification of a glassy 
carbon electrode (GCE) with carbon black (CB) using poly(allylamine hydrochloride) (PAH) 
as a dispersant agent. The sensor (CB-PAH/GCE) was electrochemically characterized by 
cyclic voltammetry and electrochemical impedance spectroscopy, and the experiments 
demonstrated that the presence of CB contributed to the decrease in charge transfer resistance 
of the sensor. The CB-PAH/GCE was applied for voltammetric determination of dopamine 
(DA), paracetamol (PAR), amlodipine (AML) and rosuvastatin (RSV). Under the optimized 
experimental conditions in linear sweep voltammetry, DA, PAR, AML, and RSV presented a 
linear dependence to the anodic peak current within the range of 1.0 – 22; 2.4 – 27; 12 – 90; 
7.8 – 40 µM, with a limit of detection of 0.17; 0.13; 1.02; 0.82 µM, respectively. The sensor 
was successfully applied to the simultaneous determination of DA, PAR, AML and RSV in 
pharmaceutical and environment samples, and DA, PAR in biological sample. 
 







 Electrochemical chemical sensing offersThe modification of the electrode surface makes 
possible to control surface/solution interaction and solve problems such as slow electron 
transfer in electrochemical processes, and high overpotential of the redox process.1,2 Carbon 
black (CB) is a nanomaterial with amorphous carbon in its structure, and it has attracted a lot 
of attention because of its advantageous properties, such as high superficial area, excellent 
conductivity, chemical and physical stability, and its low cost in comparison with other carbon 
materials.3 According to Vicentini and collaborators, CB Vulcan XC-72R has produced 
enhanced electrochemical performance and presented better surface coating.4 
For the immobilization of CB on the surface of the glassy carbon electrode (GCE), several 
materials have been reported in the literature, such as Nafion,5 dihexadecylphosphate6 and 
carboxymethylated polysaccharide.7 Another material that can be used for the immobilization 
of CB on the GCE surface is poly(allylamine hydrochloride) (PAH), however, it has not 
previously been described for this purpose. PAH is a weak cationic polyelectrolyte, which 
comprises of many ionizable amine groups. Thus, when in acidic or basic solution it is fully 
protonated, while in neutral solutions it is partially deprotonated.8  
Rosuvastatin calcium (RSV) is a member of the statin family used to treat high cholesterol. 
The rate controlling enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase 
controls the production of cholesterol. High cholesterol can lead to a build up of low-density 
lipoproteins (LDL) in arteries, restricting blood flow. RSV is a selective and competitive 
inhibitor of HMG-CoA reductase, which results in a marked reduction in serum low-density 
lipoprotein (LDL) levels.9,10 The majority of hyperlipidemic patients may also have 
hypertension problems, thus antihypertensive and antihyperlipidemic agents are commonly 
administered in combination.11 Amlodipine besylate (AML) is a calcium channel blocker, and 
it is generally used in the management of hypertension and angina pectoris.12 Both drugs are 
co-administered for the simultaneous treatment of hypertension and high cholesterol.Recent 
studies show that pre-existing hypertension may be a risk factor for Parkinson’s disease 
diagnosis,11 where low levels of dopamine are present in the human body. Dopamine (DA) is 
a neurotransmitter in mammalian brain tissue that plays a major physiological role in the 
functioning of the central nervous, renal, hormonal and cardiovascular systems as an 
extracellular chemical messenger.13 Paracetamol (PAR) or acetaminophen is among the most 
extensively employed drugs in the world, it is used to relieve moderate pain and the symptoms 
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of fevers.14 Furthermore, 50% of the patients with Parkinson disease manifest significant 
pain,15 thereby it is common practice to prescribe PAR to relieve chronic pain caused by loss 
of motor function. Recent published data suggests that low concentrations of PAR significantly 
reduced DA neurodegeneration while a high concentration of PAR did not protect DA neurons 
6-hydroxydopamine-induced degeneration.15 
Thereby, the determination of drugs of different therapeutic classes is very important for human 
health, to monitor their concentration in plasma, and for environmental protection, due to 
inappropriate disposal protocols. Several publications describe methods for individual and 
simultaneous determination of DA, PAR, AML, and RSV, among them, chromatography,16–20 
and spectrophotometry.21–23 However, these techniques present some disadvantages such as 
high instrumentation cost, long analysis time, and extensive sample preparation. In these 
circumstances, electroanalytical techniques appear as an alternative method. They are simple, 
rapid, portable, highly sensitive, selective, and environmentally friendly. In the literature, there 
are reports of the voltammetric determination of DA, PAR, AML and RSV,7,24–28 although 
there is not for this quaternary determination. 
This paper describes for the first time a new electrochemical platform based on the 
immobilization of CB on the GCE surface employing PAH as a dispersant agent. The new 
sensor has been applied for the simultaneous determination of DA, PAR, AML, and RSV in 




Reagents and solutions 
 
All chemicals used were of analytical grade and used as received without any further 
purification. CB VXC72R was kindly provided by Cabot Corporation (São Paulo – SP, Brazil). 
All solutions were prepared with ultra-purified water (resistivity ≥ 18.2 MΩ cm) supplied by a 
Milli-Q system (Millipore®, USA). 
DA, PAR, AML, and RSV (purity ≥ 99.5%) were obtained from Sigma-Aldrich (USA). 
Potassium monobasic phosphate, potassium dibasic phosphate, acetic acid, boric acid, 
phosphoric acid, ascorbic acid, citric acid, sodium hydroxide, potassium chloride, and sodium 
chloride were purchased from Anidrol (Brazil). For the simulated blood serum: bovine serum 




Pharmaceutical samples were purchased from a drugstore, in Londrina, Brazil. The 
tablets were labelled 5 mg mL-1 and 500 mg mL-1 for DA and PAR, respectively. The besylate 
amlodipine tablet was labelled 3.48; 6.93; 13.9 mg mL-1 (which, for amlodipine, the 
concentrations were 2.5; 5.0; 10 mg mL-1), and the calcium rosuvastatin tablet was labelled 
5.20; 10.4; 20.8 mg mL-1 (which, for rosuvastatin the concentrations were 5.0; 10.0; 20.0 mg 
mL-1). 
The tap water sample was collected from a tap at Universidade Estadual de Londrina, 
Londrina, Brazil. The river water sample was collected from a local river (Ribeirão Cambé, 
Brazil). 
The electrolyte supporting solutions were: BR buffer solutions (pH 2.0 – 5.0), 
phosphate buffer solution (pH 2.0), and KCl 0.5 mol L-1. The BR buffer solutions were 
prepared with acetic, phosphoric and boric acids, and the pH adjusted with a 2.0 mol L-1 NaOH 
solution. The phosphate buffer solution was prepared with a 0.1 mol L-1 potassium monobasic 
phosphate solution and the pH was adjusted with 0.1 mol L-1 potassium dibasic phosphate. 
Stock solutions of DA and PAR were prepared in deionized water at 10 mmol L-1 
concentration. AML was dissolved in ethyl alcohol and RSV in propanone both at 10 mmol L-
1 concentration. Their working solutions (1 mmol L-1) were made by appropriate dilution of 




Voltammetric measurements were carried out using a PGSTAT-101 
potentiostat/galvanostat (Metrohm Autolab B. V., Netherlands) controlled by NOVA 2.1 
software. This was coupled to a three-electrode single-compartment glass cell containing an 
Ag/AgCl (3.0 mol L-1 KCl) as the reference electrode, a platinum plate as an auxiliary 
electrode, and bare GCE or modified-GCE as working electrodes. GCE was obtained from 
Tokay Carbon Co., Japan (3 mm, diameter). 
Electrochemical impedance spectroscopy (EIS) measurements were performed on a 
FRAII μAutoLab type III potentiostat/galvanostat (Metrohm Autolab B. V., Netherlands) 
controlled by NOVA 1.0 software. These experiments were performed using 1.0 mmol L-1 
hexaammineruthenium(III) chloride in 0.1 mol L-1 KCl in the range from 0.1 Hz to 100 kHz 
(10 points per decade) and with a 10 mV (r.m.s) ac perturbation. 
Microscopy images were obtained by a scanning electron microscope (SEM) FEI 
Quanta 200 FEG operated at 5 kV. 
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Individual spectrophotometric determination of DA, PAR, AML, and RSV were 
conducted on a PerkinElmer lambda 40 UV-Vis spectrometer coupled at a computer, a 1-cm 
quartz cell was used. 
 
Preparation of CB-PAH/GCE 
 
The preparation of CB-PAH/GCE was realized according to the following steps (Fig. 
1). First, the bare GCE was carefully polished with diamond spray 1-µm particle size, and in 
sequence with ¼-µm particle size (Kemet, UK) on a polishing cloth. Afterward, a CB-PAH 
dispersion was prepared by weighing 2 mg of CB and 1 mg of PAH, which was dispersed in 1 
mL of ultra-purified water with the aid of an ultrasonic bath. The CB-PAH modified GCE was 
produced via a drop-cast process, 8 µL of CB-PAH dispersion was immobilized on the bare 
GCE surface. The electrode was left to dry for 1 hour at room temperature. 
 
 





Cyclic voltammetry (CV) was used for the electrochemical characterization of the 
electrode surfaces and the voltammetric behaviour of DA, PAR, AML, and RSV. The 
simultaneous determination of the analytes in pharmaceutical, biological and environmental 
samples was performed using linear sweep voltammetry (LSV). After optimizing the 
experimental parameters, the analytical curve was constructed by the addition of aliquots of a 
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standard solution of DA, PAR, AML, and RSV into the electrochemical cell containing 
phosphate buffer solution (pH 2.0). All measurements were carried out in triplicate (n = 3) for 
each concentration. The limit of detection (LOD) was calculated according to three times the 
standard deviation of the blank solution divided by the slope of the analytical curve. 
 
Preparation of the pharmaceutical samples 
 
The pharmaceutical samples were prepared in four combinations, namely sample A, 
sample B, sample C, and sample D, with different concentrations of each analyte, as shown in 
Table 1. To prepare the injectable-DA sample, an aliquot was transferred into a 20 mL 
volumetric flask containing phosphate buffer solution (pH 2.0); then an aliquot of 120 µmol L-
1 was transferred to the electrochemical cell. For PAR, AML and RSV ten tablets of each 
respective pharmaceutical formulation were weighed and reduced to a homogeneous fine 
powder in a mortar. An amount of these powders corresponding to one simple tablet was 
weighed and transferred to calibrated volumetric flasks. PAR was transferred to 25 mL of 
phosphate buffer solution (pH 2.0), AML to 5 mL of ethyl alcohol, and RSV to 5 mL of acetone. 
Afterward, aliquots of each sample solution were directly transferred to the electrochemical 
cell containing phosphate buffer solution (pH 2.0). The concentration of each sample solution 
was determined directly by the interpolation of the previously obtained analytical curve. These 
measurements were carried out in triplicate and the relative standard deviation (RSD) was 
calculated. 
 
Table 1 Preparation of the pharmaceutical samples and the respective concentration of DA, 
PAR, AML and RSV 
 Amount 
 DA / mg mL-1 PAR / mg tablet-1 AML / mg tablet-1 RSV / mg tablet-1 
Sample A 5.0 500 3.48 5.20 
Sample B 5.0 500 6.93 10.4 
Sample C 5.0 500 13.9 20.8 




Preparation of the biological and water samples 
 
A solution of simulated blood serum was prepared by mixing the following reagents 
(adapted from Krebs):29 ascorbic acid (10 mg L-1), BSA (40 mg L-1), citric acid (25 mg L-1), 
creatine (10.7 mg L-1), creatinine (4.2 mg L-1), glycine (17.7 mg L-1), glucose (200 mg L-1) 
lysine (29.5 mg L-1), and uric acid (10 mg L-1) in phosphate buffer saline (PBS) solution 0.1 
mol L-1 (pH 7.4). 
The river and tap water were spiked with a standard solution of DA, PAR, AML, and 
RSV of known concentration, and then 1.0 mL was transferred to the electrochemical cell 
containing 9.0 mL of PBS (pH 2.0). Recovery tests were performed to evaluate the accuracy 
of the method.  
 
Results and discussion 
 
Morphological and electrochemical characterization of the proposed carbon-based sensor 
  
The surface characterization of the GCE and CB-PAH/GCE sensors were performed 
by SEM analysis. As shown in Fig. 2B, the surface of the GCE modified with the CB-PAH 
composite presented a significant difference when compared to the unmodified GCE surface 
(Fig. 2A), indicating the formation of a homogeneous film of the CB particles covered with the 
PAH polymer.  
 
 




Considering that carbon black particles are produced by incomplete combustion or 
thermal decomposition of gas or liquid hydrocarbons, the miscibility in water is not favored 
due to the non-polar character of this nanomaterial. On the other hand, PAH is a cationic 
polyelectrolyte based on a hydrophobic chain with some ionizable amine groups along with 
the structure. The composite CB-PAH is based on the hydrophobic interaction between the CB 
particles and the carbon chain on the PAH structure. The degree of ionization of 
poly(allylamine hydrochloride), at pH 7.0 (experimental condition of this study), is 
approximately 95% for the amine groups.8 As seen in Figure 3A, the miscibility of CB particles 
in water is highly favored in the presence of PAH polymer. The ion-dipole interaction between 
the ionized amino groups and the dipole from the water molecules ensures a more stable and 
homogeneous dispersion of CB particles in water (Fig. 3B). 
 
 
Fig. 3 Photographs of (A) CB-PAH composite dispersion and (B) CB particles dispersion in 
water. 
 
Electrochemical characterization was performed by cyclic voltammetry and EIS. For 
both techniques, the electrochemical behaviour of bare GCE, PAH/GCE, and CB-PAH/GCE  
were studied using 1.0 mmol L-1 hexaammineruthenium(III) chloride in 0.1 mol L-1 KCl. Fig. 
4 shows the cyclic voltammograms (50 mV s-1) for GCE, PAH/GCE, and CB-PAH/GCE, it is 
possible to observe a peak-to-peak separation (∆Ep) of 0.0696, 0.0801 and 0.0571 V, 
respectively. Thereby, the introduction of CB on the PAH film improved the electron transfer 
when compared with the bare GCE and PAH-GCE. 
Electroactive area of the electrodes was calculated using Randles-Sevcik equation30 and 
a diffusion coefficient for hexaammineruthenium(III) chloride of 9.1 × 10-6 cm2 s-2. The 
electroactive area of bare GCE, PAH/GCE, and CB-PAH/GCE was calculated as 0.057, 0.044 
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and 0.133 cm2, respectively. The results show that CB increases the electroactive area of the 
sensor, as expected when using a nanomaterial.  
 











E (V) vs Ag/AgCl
 
Fig. 4 Cyclic voltammograms (50 mV s-1) in KCl 0.1 mol L-1 in the presence of 1.0 mmol L-1 
hexaammineruthenium(III) chloride, using as working electrode: (‒‒) bare GCE, (‒‒) 
PAH/GCE, and (‒‒) CB-PAH/GCE. 
 
Modified electrochemical devices can be studied by methods based on impedance 
measurements, associated with electronic transfer kinetics. The electrochemical 
characterization of the GCE, PAH/GCE and CB-PAH/GCE sensors was performed based upon 
the electrochemical impedance spectroscopy (EIS) using the well-know electrochemical probe, 
hexacyanoferrate system [Fe(CN)6]
3-/4-. The Randles circuit is the most common model used 
for impedance measurements, including only solution resistance (RSOL), a parallel combination 
of a double-layer capacitor (CPE – constant phase element) and a charge transfer or 
polarization resistance (RCT), as represented in the circuit shown in Fig. 5 (inset).  
Nyquist’s plot of a Randles cell is a semicircle and the diameter represents the charge 
transfer resistance (at higher frequencies), while the straight line at an angle of 45° to the real 
axis at lower frequencies represents the diffusion process (mass transfer control). As can be 
seen in Fig. 5, the addition of the polyelectrolyte (PAH) caused an increase in RCT (1.2 kΩ) 
compared to the bare GCE (RCT = 0.32 kΩ). This behaviour can be attributed to the organic 
macromolecular film (PAH) that can block the diffusion of electroactive species on the 
electrode surface. The introduction of the composite (CB-PAH/GCE) caused a 
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physicochemical alteration at the electrode/solution interface, decreasing the semi-circle radius 
(RCT 0.05 kΩ) compared to the other sensors. This result suggests that the nanomaterial 
increased the electron transfer rate in the electrochemical system, as expected.  
 
Fig. 5 Nyquist diagram to (■) bare GCE, (●) PAH/GCE and (▲) CB-PAH/GCE in 0.1 mol L-
1 KCl containing 1.0 mmol L-1 hexaammineruthenium (III) chloride, open circuit mode (inset 
A), 10 mV amplitude and frequency range of 10 Hz to 100 kHz. Insert: magnifications of the 
high-frequency part of the impedance spectra for the bare GCE. 
 
Application of CB-PAH/GCE for multianalyte determination of DA, PAR, AML and RSV 
 
 The electrochemical behaviour of DA, PAR, AML, and RSV were compared by cyclic 
voltammetry (50 mV s-1) using, as working electrode, a bare GCE, PAH-GCE, and CB-
PAH/GCE in BR buffer (pH 3.0) in the presence of 0.4 mmol L-1 of each analyte. In Fig. 6, it 
is possible to observe that DA, PAR, AML, and RSV presented a well-defined oxidation peak 
at 0.44, 0.63, 0.90 and 1.32 V, respectively vs. Ag/AgCl (KCl 3.0 mol L-1). DA and PAR show 
characteristic quasi reversible processes, presenting reduction peak on the reverse scan. On the 
other hand, no reduction peaks were observed to AML and RSV, indicating that the oxidation 
process is irreversible. When the CB is incorporated on the PAH film it is possible to observe 
an improvement in the electrochemical response of all analytes. This is due to the nanometre 
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scales of the CB that provide an increased electroactive area and faster charge transfer, as 
previously mentioned in the electrochemical characterization of the sensor.  
 






























Fig. 6 Cyclic voltammograms (50 mV s-1) recorded in BR buffer solution (pH 3.0) in the 
presence of DA, PAR, AML and RSV at 0.4 mmol L-1 concentration with the working electrode 
(‒‒) bare GCE, (‒‒) PAH/GCE, and (‒‒) CB-PAH/GCE. Inset: magnifications of the cyclic 
voltammograms using (‒‒) bare GCE, (‒‒) PAH/GCE as working electrodes, under the same 
conditions.  
 
 The effect of the amounts of CB and PAH on the analytical responses was studied using 
BR buffer solution (pH 3.0) in the presence of DA, PAR, AML, and RSV at 0.4 mmol L-1 
concentration by CV (data not shown). In this study, the ratio between CB and PAH was 1:1, 
1:2, 2:1, 3:1 (m/m; CB:PAH). The dispersion of 2:1 (m/m; CB:PAH) showed a higher current 
magnitude and better repeatability. Thereby, this dispersion was chosen for all further 
electrochemical experiments. 
 The fabrication reproducibility of the CB-PAH/GCE was studied by CV and using three 
different sensors, which were constructed using the same and then three different dispersions 
of CB-PAH (2:1; m/m). The measurements were performed in the presence of DA, PAR, AML 
and RSV at 0.4 mmol L-1 concentration in BR buffer solution (pH 3.0). For the same dispersion, 
the RSD values were 1.99%, 1.33%, 1.78% and 1.49% for DA, PAR, AML and RSV, 
respectively, and for the three different dispersions the RSD values were 2.55%, 0.78%, 1.37% 
and 0.85% for DA, PAR, AML and RSV, respectively. The results demonstrated the viability 
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and high reproducibility of the fabrication of CB-PAH/GCE. Under the same conditions, 
repetitive current measurements were performed in order to investigate the CB-PAH/GCE 
stability. After 35 measurements, the current decreased only 5.0% of its original value, 
indicating good stability of the film of CB-PAH formed on the GCE surface. 
 
Study of pH, supporting electrolyte and effect of scan rate 
 
 The pH of the supporting electrolyte was studied between 2.0 to 5.0 using a BR buffer 
solution. Above pH 6.0, the peak current for RSV vanishes. pH 2.0 was chosen for the 
simultaneous determination of DA, PAR, AML, and RSV, due to the highest magnitude and 
repeatability. In sequence, the effect of the supporting electrolyte on the oxidation peak of DA, 
PAR, AML, and RSV was comparatively investigated for BR and phosphate buffer solutions 
(0.1 mol L-1) at pH 2.0. Better repeatability and higher peak current were obtained employing 
a phosphate buffer solution, which was selected.  
 The effect of scan rate on the oxidation peak of DA, PAR, AML, and RSV at 0.3 mmol 
L-1 concentration using CB-PAH/GCE in phosphate buffer solution (pH 2.0) was investigated 
by CV at different scan rates from 5 – 350 mV s-1. Fig. 7 shows all the voltammograms and 
plots of the logarithm of the oxidation peak current (log Iap) vs. logarithm of the scan rate (log 
v). As can be seen, the plots log Iap vs. log v are linear with slope values around the theoretical 
value to 1.0, characteristic of a system controlled by adsorption. The corresponding equations 
are: 
 
DA: log Iap = − 1.19 + 1.22 log v (r = 0.994)  (Eq. 1) 
 
PAR: log Iap = − 0.61 + 1.16 log v (r = 0.996) (Eq. 2) 
 
AML: log Iap = − 0.26 + 0.97 log v (r = 0.999) (Eq. 3) 
 
RSV log Iap = − 0.16 + 0.85 log v (r = 0.995)  (Eq. 4) 
 
Additionally, the oxidation peak current (Iap) vs. scan rate (v) were plotted, and a linear 
behaviour was obtained for DA, PAR, AML and RSV, reaffirming that the process is 
predominantly controlled by adsorption on the CB-PAH/GCE surface. In the voltammograms, 
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it was possible to observe, for all analytes, an increase of potential to more positive potentials, 
which is a characteristic of quasi reversible and irreversible processes. 
 
 
Fig. 7 Cyclic voltammograms obtained at different scan rates (a – i: 5 – 350 mV s-1) for DA, 
PAR, AML and RSV at 0.3 mmol L-1 concentration in phosphate buffer solution (pH 2.0). 
Inset: Plots of (I) log Ipa vs. log v and (II) Ipa vs. v
1/2. 
 
 The number of electrons involved in the electrochemical oxidation of DA, PAR, AML, 
and RSV were estimated using the cyclic voltammograms obtained at 50 mV s-1 and applying 
the equation Eap – Eap/2 = 0.047/αn.
30 The value of Eap and Eap/2 were 0.495 and 0.457 for DA; 
0.715 and 0.676 V for PAR; 0.962 and 0.906 for AML; 1.257 and 1.188 V for RSV, 
respectively. Assuming α value as 0.5 (commonly employed),30 the number of electrons 
involved in the oxidation of DA, PAR and AML are 2, and for RSV is 1 employing the CB-
PAH/GCE. These values are according to the literature.7,31 The electrochemical oxidation of 
DA happens in both phenol groups and 2 electrons and 2 H+ are released, for PAR the 
oxidations are in the phenol and amine groups with the release of 2 electrons and 2 H+.33 The 
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electrochemical oxidation of AML occurs in the amine group and release 2 electrons and for 
the RSV the oxidation occurs in the alcohol group, and 1 electron is released.34,35 
 
Simultaneous determination of DA, PAR, AML and RSV employing the CB-PAH/GCE 
 
Prior to the analytical curve construction, the influence of the scan rate on the sensitivity 
of LSV was investigated. For this purpose, analytical curves were constructed for each 
evaluated value in a scan rate range of 10 to 100 mV s-1. Based on these curves, due to a better 
sensitivity and linearity, the scan rate of 75 mV s-1 was chosen for the analytical curve 
construction. 
Under these chosen conditions, the analytical curve of each analyte in the presence of 
the ternary mixture of other analytes was performed by changing the concentrations of one 
analyte and maintaining the concentration of each of the three analytes constant. All results 
obtained employing the CB-PAH/GCE were summarized in Table 2. The peak oxidation 
currents of the analytes that remained constant present RSD values smaller than 8.65%, 
indicating that the change of concentration of one studied analyte did not have a significant 
influence on the voltammetric response of the other one.  
 
Table 2 Slope and RSD values obtained from LSV technique for the simultaneous 
determination of one analyte in the presence of the ternary mixture of other analytes employing 
the CB-PAH/GCE for DA, PAR, AML and RSV 
Analyte Slope / µA µmol L-1 Correlation coefficient 
RSD (%) 
DA PAR AML RSV 
Dopamine 0.362 0.999 − 3.69 8.65 4.61 
Paracetamol 0.205 0.999 2.43 − 4.90 1.94 
Amlodipine 1.103 0.995 5.73 4.49 − 5.12 
Rosuvastatin 0.471 0.997 3.85 4.92 7.07 − 
 
 Then, the analytical curves were constructed by successive additions of a standard 
solution of DA, PAR, AML and RSV by LSV employing the CB-PAH/GCE in phosphate 
buffer solution (pH 2.0). Fig. 8 shows the linear sweep voltammograms obtained for the 
solution containing DA, PAR, AML and RSV, and the respective analytical curves for each 
16 
 
analyte. The analytical parameters obtained to the simultaneous determination of DA, PAR, 
AML, and RSV are listed in Table 3. 
 
 
Fig. 8 (A) Linear sweep voltammograms obtained employing the CB-PAH/GCE for various 
concentrations of (2-7) DA (1.0 – 22 µmol L-1), PAR (2.4 – 27 µmol L-1), AML (12 – 90 µmol 
L-1), and RSV (7.8 – 40 µmol L-1). Respective analytical curves for (B) DA, (C) PAR, (D) 
AML, (E) RSV. 
 
Table 3 Analytical parameters for simultaneous determination of DA, PAR, AML and RSV 
by LSV in phosphate buffer solution (pH 2.0) employing the CB-PAH/GCE 
Analytical parameters 
Analytes 
DA PAR AML RSV 
Peak potential (V) 0.47 0.66 0.90 1.27 
Linear range (µmol L-1) 1.0 – 22 2.4 – 27 12 – 90 7.8 – 40 
Correlation coefficient 0.999 0.999 0.992 0.998 
Slope (µA µmol L-1) 0.38 0.18 0.27 0.54 
LOD (µmol L-1) 0.17 0.13 1.02 0.82 
 
The intra- and inter-day repeatability studies were performed using a concentration of 
15 µmol L-1 for DA and PAR, and 30 µmol L-1 for AML and RSV in phosphate buffer solution 
(pH 2,00) employing the CB-PAH/GCE. The intra-day repeatability was determined by 
successive measurements (n = 10), and the RSD values obtained were 1.99% (DA), 1.86% 
(PAR), 4.07% (AML) and 1.82% (RSV). The inter-day repeatability was assessed by 
measuring the peak current over a period of 5 days, and the RSV values obtained were 5.03% 
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(DA), 4.82% (PAR), 3.36% (AML) and 5.16% (RSV). The RSD values obtained indicated that 
the proposed method employing the CB-PAH/GCE provides good repeatability for the 
determination of these four analytes. 
Table 4 compares the linear range obtained by CB-PAH/GCE employing LSV with 
those in the literature obtained by different electrodes and techniques. Although the electrodes 
described in the literature present a better linear concentration range, with lower 
concentrations, they cannot perform the simultaneous determination for DA, PAR, AML, and 
RSV, consequently, the CB-PAH/CB has its advantages, because it enables the simultaneous 
determination. Moreover, CB-PAH/GCE is easy to prepare and demonstrates that PAH 
disperses CB very well in an aqueous medium. 
 
Table 4 Comparations of linear concentration ranges for the electrochemical determination of 
DA, PAR, AML and RSV using differents electrodes 
Electrode Technical 
Linear concentration range (µmol L-1) 
Ref. 
DA PAR AML RSV 
Platinum SWV – – 9.0 – 70 5.0 – 40 [24] 
Bi/Nafion/BDDE DPV – 0.2 – 500 – – [25] 
RGO-GCE DPV 0.1 – 100 – – – [28] 
MOFs/MWCNT-
Au@Ag/GCE 
DPV 0.6 – 70 1.0 – 40 – – [32] 
CB-PAH/GCE LSV 1.0 – 22 2.4 – 27 12 – 90 7.8 – 40 
This 
work 
Abbreviations. SWV: square-wave voltammetry; DPV: differential pulse voltammetry; 
Bi/Nafion/BDDE: bismuth particles Nafion covered boron-doped diamond electrode; 
MOFs/MWCNT-Au@Ag/GCE: metal-organic framework/multiwalled carbon nanotubes-
Au@Ag core shell nanoparticles on GCE. 
 
Selectivity and analytical application of the CB-PAH/GCE for the simultaneous determination 
of DA, PAR, AML and RSV 
 
 To evaluate the selectivity of the CB-PAH/GCE by LSV, different chemical species 
were selected, such as sodium bisulfite, starch, microcrystalline cellulose, silicon dioxide, 
creatine, creatinine, glucose, and inorganic ions as Na+, Fe2+, Zn2+, Ca2+, NO3
- and SO4
2-. For 
this, DA, PAR, AML, and RSV at 30 µmol L-1 concentration were used in the absence and 
presence of possible interfering agents at the same concentration of the analytes (30 µmol L-1) 
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in the ratio of 1:1 and 1:10. The results show that the current intensity for all analytes does not 
suffer interference from any of these chemical species with RSD lower than 7%. 
 Thereby, the CB-PAH/GCE was applied for simultaneous voltammetric determination 
of DA, PAR, AML, and RSV in pharmaceutical samples  in different concentrations (described 
in the experimental section). Table 5 presents the results obtained for this determination. As 
can be seen, there are no significant differences between the values found for DA, PAR, AML, 
and RSV in pharmaceutical samples employing LSV and spectrophotometric method.33,34 The 
paired Student t-test was applied to the statistical comparison between the voltammetric 
method and the spectrophotometric method at a confidence level of 95%. The texperimental values 
calculated were smaller the tcritical value (3.18). Additionally, the F-test provided information 
about the precision of both methods. As can be noted, all calculated values were lower than the 
Fcritical (19.0; 95% confidence interval). Thus, it is possible to conclude that there is no 






Table 5 Results obtained to the simultaneous determination of DA, PAR, AML and RSV in 
combined forms using the LSV method compared with spectrophotometric method 
  Amounta   
Sample Analyte Label value LSV method 
Reference 
method 
E (%)b Fcalcc 
A 
DA 5 mg mL–1 4.97 ± 0.13 5.02 ± 0.12 −0.99 1.17 
PAR 500 mg tablet–1 490 ± 4.7 495 ± 5.8 −1.02 0.66 
AML 3.47 mg tablet-1 3.42 ± 0.13 3.58 ± 0.11 −4.68 1.40 
RSV 5.2 mg tablet-1 5.04 ± 0.10 5.15 ± 0.08 −2.18 1.56 
B 
DA 5 mg mL–1 5.15 ± 0.12 5.06 ± 0.10 1.78 1.44 
PAR 500 mg tablet–1 514 ± 5.5 491± 6.9 4.47 0.64 
AML 6.93 mg tablet-1 6.71 ± 0.21 7.15 ± 0.18 −6.70 1.36 
RSV 10.4 mg tablet-1 10.2 ± 0.20 9.98 ± 0.27 2.07 0.55 
C 
DA 5 mg mL–1 4.90 ± 0.10 5.12 ± 0.11 −4.29 0.83 
PAR 500 mg tablet–1 508 ± 5.1 516 ± 6.1 −1.57 0.70 
AML 13.87 mg tablet-1 13.55 ± 0.67 13.84 ± 0.34 −2.14 3.88 
RSV 20.8 mg tablet-1 21.1 ± 0.35 20.5 ± 0.44 2.84 0.63 
D 
DA 5 mg mL–1 5.11 ± 0.13 4.99 ± 0.15 2.40 0.75 
PAR 500 mg tablet–1 492 ± 5.0 507 ± 4.5 −3.05 1.23 
AML 13.87 mg tablet-1 13.95 ± 0.56 13.66 ± 0.26 2.07 4.64 
RSV 5.2 mg tablet-1 5.15 ± 0.08 5.4 ± 0.14 −3.30 0.33 
aAverage of 3 measurements. 
b(LSV method – spectrophotometric method / spectrophotometric method) × 100. 
cCritical F-value = 19.0 (95% confidence level). 
 
 The CB-PAH/GCE was also employed for simultaneous determination of DA, PAR, 
AML, and RSV in environmental samples (river and tap water) and for the simultaneous 
determination of DA and PAR in biological samples (simulated blood serum). Environmental 
samples were spiked with two different concentration of each analyte: 2.0 and 5.0 µmol L-1 for 
DA; 5.0 and 10 µmol L-1 for PAR; 20 and 30 µmol L-1 for AML; 10 and 20 µmol L-1 for RSV. 
As shown in Table 6, excellent recovery percentages were obtained, demonstrating the 




Table 6 Results obtained from the analysis of environmental samples 
Analyte 














2.0 1.95 ± 0.3 97.5 2.0 1.97 ± 0.4 98.5 
5.0 4.98 ± 0.2 99.6 5.0 5.04 ± 0.3 100.8 
PAR 
5.0 4.91 ± 0.6 98.2 5.0 4.93 ± 0.6 98.6 
10 10.08 ± 0.5 100.8 10 9.96 ± 0.4 99.6 
AML 
20 21.01 ± 0.9 105.05 20 21.03 ± 0.8 105.15 
30 28.98 ± 1.1 96.6 30 30.87 ± 1.1 102.9 
RSV 
10 9.92 ± 0.7 99.2 10 9.88 ± 0.9 98.8 
20 20.51 ± 0.9 102.55 20 19.85 ± 0.8 99.25 
aAverage of 3 measurements. 
bRecovery percentage = (Found/Added) × 100. 
 
 Another applicability of the CB-PAH/GCE was in the simulated blood serum. This 
sample was spiked with two different concentrations of each analyte, 2.0 and 5.0 µmol L-1 for 
DA, and 5.0 and 10 µmol L-1 for PAR. The recovery percentages obtained were in the range of 
97.1 to 101.2% and 98.3 to 102.4% for 2.0 and 5.0 µmol L-1 DA and 99.6 to 103.2% and 98.6 
to 102.8% for 5.0 and 10.0 µmol L-1 PAR, respectively, indicating that the matrix analysed did 
not cause any interference. The excellent recovery percentages indicate that the CB-PAH/GCE 





 The proposed electrochemical sensor (CB-PAH/GCE) presented a good analytical 
performance for the simultaneous determination of DA, PAR, AML, and RSV, providing high 
sensitivity and low limits of detection. The promising results obtained can be attributed to the 
nanomaterial used for the modification of the GCE surface, which increased the electroactive 
surface area and facilitated the electronic transfer on the electrode/solution interface, as proved 
by EIS data. The simultaneous determination of DA, PAR, AML, and RSV was successfully 
demonstrated in pharmaceutical, river and tap water samples, without any significant matrix 
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interference. Additionally, the developed sensor was applied for the simultaneous 
determination of DA and PAR in biological samples (simulated blood serum). The sensing 
platform presented in this study appears to have wide applications in the multianalyte 
determination, with fast response time, low cost for fabrication and applicability to real and 
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